NaviFUS Corp. (6872.TWO)

TWD 25.65

(9.85%)

Revenue Summary of NaviFUS Corp.

  • NaviFUS Corp.'s latest annual revenue in 2023 was 22.48 Million TWD , up 15.13% from previous year.
  • NaviFUS Corp.'s latest quarterly revenue in 2024 Q1 was - TWD , down -100.0% from previous quarter.
  • NaviFUS Corp. reported a annual revenue of 19.52 Million TWD in annual revenue 2022, down 0.0% from previous year.
  • NaviFUS Corp. reported a annual revenue of - TWD in annual revenue 2021, down 0.0% from previous year.
  • NaviFUS Corp. reported a quarterly revenue of 5.15 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • NaviFUS Corp. reported a quarterly revenue of 948 Thousand TWD for 2023 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of NaviFUS Corp. (2023 - 2019)

Historical Annual Revenue of NaviFUS Corp. (2023 - 2019)

Year Revenue Revenue Growth
2023 22.48 Million TWD 15.13%
2022 19.52 Million TWD 0.0%
2021 - TWD 0.0%
2020 - TWD 0.0%
2019 - TWD 0.0%

Peer Revenue Comparison of NaviFUS Corp.

Name Revenue Revenue Difference
SYN-TECH Chem. & Pharm. Co., Ltd. 1.11 Billion TWD 97.983%
Level Biotechnology Inc. 660.61 Million TWD 96.597%
Sagittarius Life Science Corp 440.46 Million TWD 94.896%
NeoCore Technology Co., Ltd. 64.72 Million TWD 65.269%
TaiMed Biologics Inc. 491.77 Million TWD 95.429%
GlycoNex Incorporation 2.54 Million TWD -784.382%
VBI 55.85 Million TWD 59.75%
GeneReach Biotechnology Corp. 225.46 Million TWD 90.029%
Taiwan Advance Bio-Pharmaceutical Inc. 315.98 Million TWD 92.885%
Visgeneer Inc. 147.99 Million TWD 84.81%
Mycenax Biotech Inc. 652.62 Million TWD 96.555%
Sunmax Biotechnology Co., Ltd. 1.68 Billion TWD 98.669%
G&E Herbal Biotechnology Co., Ltd. 181.44 Million TWD 87.61%
Medigen Vaccine Biologics Corporation 389.62 Million TWD 94.23%
TaiwanJ Pharmaceuticals Co., Ltd. 22.74 Million TWD 1.148%
Enimmune corporation 43.49 Million TWD 48.312%
TaiRx, Inc. 5.08 Million TWD -342.365%
CHO Pharma, Inc. - TWD -Infinity%
EirGenix Inc. 1.02 Billion TWD 97.802%
BioLASCO Taiwan Co., Ltd. 264.72 Million TWD 91.508%
Sunny Pharmtech Inc. 428.82 Million TWD 94.758%
Lin BioScience, Inc. - TWD -Infinity%
BioGend Therapeutics Co., Ltd. 109.9 Million TWD 79.546%
Feng Chi Biotech Corp. 180.57 Million TWD 87.551%
Bio Preventive Medicine Corp. 1.2 Million TWD -1761.01%
Lukas Biomedical Inc. 231.83 Million TWD 90.303%
RBC Bioscience Corporation 172.46 Million TWD 86.965%
BiOptic Inc. 228.26 Million TWD 90.152%
BRIM Biotechnology, Inc. 90 Thousand TWD -24878.889%
Shine-On BioMedical Co.,Ltd. 9.52 Million TWD -136.046%
Great Novel Therapeutics Biotech & Medicals 4.85 Million TWD -363.526%
Syngen Biotech Co.,Ltd. 1.83 Billion TWD 98.776%
Anti-Microbial Savior BioteQ Co., Ltd 728 Thousand TWD -2988.049%
SynCore Biotechnology Co.,Ltd 20.19 Million TWD -11.314%
Genomics BioSci & Tech. Co.,Ltd. 396.14 Million TWD 94.325%
Neith Corporation 39.9 Million TWD 43.661%
Advagene Biopharma Co., Ltd. - TWD -Infinity%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 141.17 Million TWD 84.076%
Sinew Pharma Inc. - TWD -Infinity%
Andros Pharmaceuticals Co.,Ltd 805 Thousand TWD -2692.671%
Greenyn Biotechnology Co., Ltd 800.51 Million TWD 97.192%
Lumosa Therapeutics Co., Ltd. 56.91 Million TWD 60.501%
AP Biosciences Inc 32.25 Million TWD 30.298%
Medigen Biotechnology Corp. 1.15 Billion TWD 98.058%
3D Global Biotech Inc. 20.63 Million TWD -8.957%
Pharmosa Biopharm Inc. 314.5 Million TWD 92.852%
Intech Biopharm Corporation 25.84 Million TWD 13.023%
Oneness Biotech Co., Ltd. 86.78 Million TWD 74.095%
Eusol Biotech Co.,Ltd. - TWD -Infinity%
TWi Biotechnology, Inc. - TWD -Infinity%
Ever Supreme Bio Technology Co., Ltd 758.39 Million TWD 97.036%
TCI GENE Inc. 333.85 Million TWD 93.266%
MegaPro Biomedical Co., Ltd 18 Thousand TWD -124794.444%
Senhwa Biosciences, Inc. 1 Million TWD -2148.1%
Taiwan Bio Therapeutics Co., Ltd 85.47 Million TWD 73.697%
NatureWise Biotech & Medicals Corporation 160.14 Million TWD 85.962%
PharmaEngine, Inc. 767.66 Million TWD 97.072%
Savior Lifetec Corporation 1.05 Billion TWD 97.86%
TaiGen Biopharmaceuticals Holdings Limited 123.13 Million TWD 81.743%
OBI Pharma, Inc. 41.54 Million TWD 45.893%
Meribank Biotech Co., Ltd 234.34 Million TWD 90.407%
Acepodia, Inc. 16.59 Million TWD -35.485%
Caliway Biopharmaceuticals Co., Ltd. 38.93 Million TWD 42.256%